Skip to main content

Published locations for Alisertib response rate in PTCL patients was 33%

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Alisertib response rate in PTCL patients was 33%

User login

  • Reset your password
  • /content/alisertib-response-rate-ptcl-patients-was-33
  • /clinicianreviews/article/195007/t-cell-lymphomas/alisertib-response-rate-ptcl-patients-was-33
  • /hematologynews/article/195007/t-cell-lymphomas/alisertib-response-rate-ptcl-patients-was-33
  • /internalmedicinenews/article/195007/t-cell-lymphomas/alisertib-response-rate-ptcl-patients-was-33
  • /oncologypractice/article/195007/t-cell-lymphomas/alisertib-response-rate-ptcl-patients-was-33
  • /hematology-oncology/article/195007/t-cell-lymphomas/alisertib-response-rate-ptcl-patients-was-33
  • /hematologytimes/article/195007/t-cell-lymphomas/alisertib-response-rate-ptcl-patients-was-33
  • /internalmedicine/article/195007/t-cell-lymphomas/alisertib-response-rate-ptcl-patients-was-33
  • /familymedicine/article/195007/t-cell-lymphomas/alisertib-response-rate-ptcl-patients-was-33